Research Studies

Center for Pediatric Inflammatory Bowel Disease Research Studies

Find research studies available to children cared for by the Center for Pediatric Inflammatory Bowel Disease team.
Appointments and referrals

Search Research Studies

Clinical trial
Children (3)
Adults (1)
Healthy Controls (1)
One-Time Visit Studies (1)
Remote (Online / Phone Call Only) Studies (1)

Clinical Trial Phases
Phase I (1)
N/A (2)

Recruitment Status
Recruiting (2)
Non-recruiting (1)

Related Specialties and Programs
Center for Pediatric Inflammatory Bowel Disease (3)

Specialty
Gastroenterology (3)

Pediatric IBD Fatigue Index, and the Pediatric IBD Disability Index Study

Kids with IBD (inflammatory bowel disease) often struggle with tiredness and difficulty doing everyday activities, which can make life harder, but there aren't good tools to measure these problems in children. This study aims to create special tools to measure fatigue and disability in kids aged 2-18. Researchers will talk to kids and their parents to find out what issues matter most and use this information, along with medical records, to design the tools. The goal is to help doctors track these problems better and improve care for children with IBD. This study is being done in collaboration with the Shaare Zedek Medical Center. Participants will be compensated for their time and effort, upon completion of the interview.

Phase: Phase I

Actively recruiting: Yes

Category: Adults, Children, One-Time Visit Studies, Remote (Online / Phone Call Only) Studies

Studying the Clinical Course of Risankizumab
Risankizumab is a medication used for the treatment of Crohn's Disease in adults and children to limit symptoms of the disease. However, as children differ more than adults in their age/weight range and the way that drugs move around their body, more information is needed to understand the factors that might affect the response to the drug in children. 

Phase: N/A

Actively recruiting: Yes

Category: Children, Healthy Controls

VEDOKIDS
This study aims to prospectively explore the real life short and longer term outcomes of Vedolizumab in pediatric inflammatory bowel disease and to develop a prediction model for treatment success based on Vedolizumab trough levels and other clinical and laboratory markers. Children under 18 years of age that have been diagnosed with IBD and their physician is starting treatment with Vedolizumab may be eligible.

Phase: N/A

Actively recruiting: No

Category: Children